NTRK3 - neurotrophic receptor tyrosine kinase 3 Gene
Species: Felis catus
Gene Type: protein coding
Gene ID: 101085548
NTRK3 Products (9)
| mRNA | Protein | Name |
|---|---|---|
| XM_045058830.1 | XP_044914765.1 | NT-3 growth factor receptor isoform X7 |
| XM_045058827.1 | XP_044914762.1 | NT-3 growth factor receptor isoform X3 |
| XM_045058825.1 | XP_044914760.1 | NT-3 growth factor receptor isoform X1 |
| XM_045058828.1 | XP_044914763.1 | NT-3 growth factor receptor isoform X5 |
| XM_045058826.1 | XP_044914761.1 | NT-3 growth factor receptor isoform X2 |
| XM_011282744.4 | XP_011281046.1 | NT-3 growth factor receptor isoform X4 |
| XM_019831909.3 | XP_019687468.1 | NT-3 growth factor receptor isoform X8 |
| XM_045058831.1 | XP_044914766.1 | NT-3 growth factor receptor isoform X9 |
| XM_011282745.3 | XP_011281047.1 | NT-3 growth factor receptor isoform X6 |
NTRK3 Protein Structure
LRR_8
LRR_8: pfam13855 (102 - 159)
LRR_1
LRR_1: sd00031 (104 - 127)
LRR_1
LRR_1: sd00031 (128 - 150)
LRR_1
LRR_1: sd00031 (151 - 163)
TPKR_C2
TPKR_C2: pfam16920 (162 - 207)
ig
ig: pfam00047 (213 - 298)
Ig
Ig: cd00096 (226 - 230)
Ig
Ig: cd00096 (239 - 243)
Ig
Ig: cd00096 (265 - 269)
Ig
Ig: cd00096 (280 - 285)
Ig
Ig: cd00096 (293 - 296)
IgI_TrKABC_d5
IgI_TrKABC_d5: cd04971 (303 - 395)
IgI_TrKABC_d5
IgI_TrKABC_d5: cd04971 (304 - 310)
IgI_TrKABC_d5
IgI_TrKABC_d5: cd04971 (312 - 315)
IgI_TrKABC_d5
IgI_TrKABC_d5: cd04971 (318 - 326)
IgI_TrKABC_d5
IgI_TrKABC_d5: cd04971 (329 - 336)
IgI_TrKABC_d5
IgI_TrKABC_d5: cd04971 (339 - 342)
IgI_TrKABC_d5
IgI_TrKABC_d5: cd04971 (347 - 353)
IgI_TrKABC_d5
IgI_TrKABC_d5: cd04971 (357 - 365)
IgI_TrKABC_d5
IgI_TrKABC_d5: cd04971 (373 - 381)
IgI_TrKABC_d5
IgI_TrKABC_d5: cd04971 (384 - 392)
PTKc_TrkC
PTKc_TrkC: cd05094 (530 - 816)
- 0
- 200
- 400
- 600
- 824 a.a.
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
NT-3 growth factor receptor |
|
Related Agents
- Clinical Phase
- Pre-clinical Phase
Clinical Phase
Bioactive Molecules
(2)
| Cat. No. | Product Name |
Effect
|
Purity |
Phase
|
|---|---|---|---|---|
| HY-131003A | Taletrectinib free base | Inhibitor | / | Phase 3 |
| HY-131003 | Taletrectinib | Inhibitor | 99.63% | Phase 2 |
Pre-clinical Phase
Bioactive Molecules
(6)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-RS09634 | NTRK3 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-W070306 | PDK1-IN-1 | Inhibitor | 99.95% | Unkown |
| HY-101977A | (R,S)-Selitrectinib | Inhibitor | / | Unkown |
| HY-115541 | BRD4-IN-41 | Inhibitor | / | Unkown |
| HY-RS09635 | Ntrk3 Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS09636 | Ntrk3 Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
Bioactive MoleculesInhibitory Antibodies
(1)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-P992308 | Anti-TrkC Antibody | / | Unkown |
Compound Screening Libraries
Virtual Screening
Customize Your Library
Drug Screening Service